Cyclotron produced isotopes in biology and medicine, project 3: Specific aim 1A and 1B effects of fatty acid delivery on myocardial metabolism and function in type 2 diabetes.

Trial Profile

Cyclotron produced isotopes in biology and medicine, project 3: Specific aim 1A and 1B effects of fatty acid delivery on myocardial metabolism and function in type 2 diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 May 2014

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Aug 2011 Planned end date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 11 May 2011 Planned end date changed from 1 Jun 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
    • 12 Feb 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top